BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grabinska K, Pelak M, Wydmanski J, Tukiendorf A, d’Amico A. Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer. World J Gastroenterol 2015; 21(19): 5901-5909 [PMID: 26019454 DOI: 10.3748/wjg.v21.i19.5901] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kobayashi S, Ogura M, Suzawa N, Horiki N, Katsurahara M, Ogura T, Sakuma H. 18F-FDG uptake in the stomach on screening PET/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis. BMC Med Imaging. 2016;16:58. [PMID: 27756255 DOI: 10.1186/s12880-016-0161-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
2 Song J, Li Z, Chen P, Yu J, Wang F, Yang Z, Wang X. A 18FDG PET/CT-based volume parameter is a predictor of overall survival in patients with local advanced gastric cancer. Chin J Cancer Res 2019;31:632-40. [PMID: 31564806 DOI: 10.21147/j.issn.1000-9604.2019.04.07] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Tang L, Wang XJ, Baba H, Giganti F. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and 18F-FDG PET/CT findings. Eur Radiol 2020;30:247-60. [PMID: 31392480 DOI: 10.1007/s00330-019-06370-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
4 Lan F, Zhu M, Qi Q, Zhang Y, Liu Y. Prognostic value of serum tumor abnormal protein in gastric cancer patients. Mol Clin Oncol 2016;5:216-20. [PMID: 27330802 DOI: 10.3892/mco.2016.877] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Fugo K, Sunaoshi T, Ozaki A, Sugiyama E, Baba A, Fukamizu Y, Kagayama S, Hasegawa R, Shirai Y, Oshima Y, Koike N, Toshimitsu Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N. Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion and positron emission tomography/computed tomography of upper gastrointestinal cancers. Abdom Imaging 2015;40:3012-9. [PMID: 26350283 DOI: 10.1007/s00261-015-0545-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Aurello P, Petrucciani N, Antolino L, Giulitti D, D'Angelo F, Ramacciato G. Follow-up after curative resection for gastric cancer: Is it time to tailor it? World J Gastroenterol 2017; 23(19): 3379-3387 [PMID: 28596674 DOI: 10.3748/wjg.v23.i19.3379] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
7 Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Tanaka S, Sunaoshi T, Kano D, Sugiyama E, Shite M, Haga R, Fukamizu Y, Fujita T, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N. Comparison of DWIBS/T2 image fusion and PET/CT for the diagnosis of cancer in the abdominal cavity. Exp Ther Med 2017;14:3754-60. [PMID: 29042975 DOI: 10.3892/etm.2017.4987] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Marcus C, Subramaniam RM. PET/Computed Tomography and Precision Medicine: Gastric Cancer. PET Clin 2017;12:437-47. [PMID: 28867114 DOI: 10.1016/j.cpet.2017.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
9 Lee SY, Seo HJ, Kim S, Eo JS, Oh SC. Prognostic significance of interim 18 F-fluorodeoxyglucose positron emission tomography-computed tomography volumetric parameters in metastatic or recurrent gastric cancer. Asia Pac J Clin Oncol 2018;14:e302-9. [PMID: 29226597 DOI: 10.1111/ajco.12833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 García Vicente AM, Pérez-Beteta J, Amo-Salas M, Pena Pardo FJ, Villena Martín M, Sandoval Valencia H, Mollejo Villanueva M, Barbella R, Klein Zampaña CJ, Borrás Moreno JM, Soriano Castrejón ÁM, Pérez-García VM. 18F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for Gliomas. Clin Nucl Med 2019;44:e548-58. [PMID: 31306196 DOI: 10.1097/RLU.0000000000002715] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
11 Manoharan V, Lee S, Chong S, Yap J, Coupe N, Wilson R, Merrett N, Ng W, Lin M. Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy. Ann Nucl Med 2017;31:315-23. [PMID: 28299585 DOI: 10.1007/s12149-017-1159-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
12 Tomizawa M, Shinozaki F, Uchida Y, Uchiyama K, Fugo K, Sunaoshi T, Ozaki A, Sugiyama E, Baba A, Kano D, Shite M, Haga R, Fukamizu Y, Kagayama S, Hasegawa R, Shirai Y, Motoyoshi Y, Sugiyama T, Yamamoto S, Kishimoto T, Ishige N. Diffusion-weighted whole-body imaging with background body signal suppression/T2 image fusion for the diagnosis of colorectal polyp and cancer. Exp Ther Med 2017;13:639-44. [PMID: 28352344 DOI: 10.3892/etm.2016.3981] [Reference Citation Analysis]
13 Dębiec K, Wydmański J, Gorczewska I, Leszczyńska P, Gorczewski K, Leszczyński W, d’Amico A, Kalemba M. 18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy. Asian Pac J Cancer Prev 2017;18:2989-98. [PMID: 29172270 DOI: 10.22034/APJCP.2017.18.11.2989] [Reference Citation Analysis]
14 Han J, Harrison L, Patzelt L, Wu M, Junker D, Herzig S, Berriel Diaz M, Karampinos DC. Imaging modalities for diagnosis and monitoring of cancer cachexia. EJNMMI Res 2021;11:94. [PMID: 34557972 DOI: 10.1186/s13550-021-00834-2] [Reference Citation Analysis]
15 Tello Galán MJ, García Vicente AM, Pérez Beteta J, Amo Salas M, Jiménez Londoño GA, Pena Pardo FJ, Soriano Castrejón ÁM, Pérez García VM. Global heterogeneity assessed with 18F-FDG PET/CT. Relation with biological variables and prognosis in locally advanced breast cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2019;38:290-7. [PMID: 31427247 DOI: 10.1016/j.remn.2019.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Schernberg A, Rivin Del Campo E, Rousseau B, Matzinger O, Loi M, Maingon P, Huguet F. Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives. Clin Transl Radiat Oncol 2018;10:13-22. [PMID: 29928701 DOI: 10.1016/j.ctro.2018.02.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
17 Perlaza P, Ortín J, Pagès M, Buxó E, Fernández-Esparrach G, Colletti PM, Rubello D, Mayoral M, Sánchez N, Ruiz C, Ginés A, Fuster D. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma? Clin Nucl Med 2018;43:402-10. [PMID: 29485442 DOI: 10.1097/RLU.0000000000002028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
18 Park JS, Lee N, Beom SH, Kim HS, Lee CK, Rha SY, Chung HC, Yun M, Cho A, Jung M. The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status. Gastric Cancer 2018;21:213-24. [PMID: 28643145 DOI: 10.1007/s10120-017-0739-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
19 Sun G, Cheng C, Li X, Wang T, Yang J, Li D. Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer. Cancer Imaging 2019;19:18. [PMID: 30902116 DOI: 10.1186/s40644-019-0205-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Kudou M, Kosuga T, Kubota T, Okamoto K, Komatsu S, Shoda K, Konishi H, Shiozaki A, Fujiwara H, Arita T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Otsuji E. Value of Preoperative PET-CT in the Prediction of Pathological Stage of Gastric Cancer. Ann Surg Oncol 2018;25:1633-9. [PMID: 29626306 DOI: 10.1245/s10434-018-6455-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]